AbstractObjectiveTo estimate population health outcomes with delayed second dose versus standard schedule of SARS-CoV-2 mRNA vaccination.DesignSimulation agent based modeling study.SettingSimulated…
Covid-19UK reclassifies variant from India as concernPublic Health England reclassified a variant of SARS-CoV-2 first detected in India (B.1.617.2) as a variant of concern, now known […]
Researchers running the University of Oxford-led Com-COV study—launched earlier this year to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine—have today reported preliminary […]
A new, noninvasive method for measuring brain blood flow with light has been developed by biomedical engineers and neurologists at the University of California, Davis, and […]